(Q34047349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

meta-analysis

0 references

title

Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Pierre Fesler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Yohan Duny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jean Ribstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Guilhem du Cailar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Albert Mimran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Max Villain

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jean P Daures

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

13 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

126-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

Blood pressure and end-stage renal disease in men

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and Women

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Association between blood pressure and the rate of decline in renal function with age

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Hypertension in the elderly. Implications and generalizability of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

The power of statistical tests in meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Results of the pilot study for the Hypertension in the Very Elderly Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind t

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque [...]

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Glucose tolerance and age-associated decline in renal function of hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Left ventricular remodeling and renal function in never-treated essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Meta-analysis of rare and adverse event data

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Nifedipine versus fosinopril in uninephrectomized diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.180

7 January 2021

Identifiers

DOI

10.1038/AJH.2011.180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993366%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference